EQS-News: MetrioPharm AG: First patient dosed in a clinical Phase II trial for MP1032 for the treatment of moderate-to-severe chronic plaque psoriasis
Dow Jones received a payment from EQS/DGAP to publish this press release. EQS Group-News: MetrioPharm AG / Key word(s): Study/Miscellaneous MetrioPharm AG: First patient dosed in a clinical Phase …
FinanzNachrichten.de: Aktuelle Nachrichten
